These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36752683)

  • 1. Untargeted metabolomics reveals altered branch chain amino acids, glucose and fat metabolism contributing to coronary artery disease among Indian diabetic patients.
    Adela R; Kasarla SS; Saquib N; Gupta SK; Bajpai S; Kumar Y; Banerjee SK
    Mol Omics; 2023 May; 19(4):321-329. PubMed ID: 36752683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes.
    Ottosson F; Smith E; Melander O; Fernandez C
    J Clin Endocrinol Metab; 2018 Aug; 103(8):3060-3069. PubMed ID: 29788285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
    Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
    J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach.
    Basak T; Varshney S; Hamid Z; Ghosh S; Seth S; Sengupta S
    J Proteomics; 2015 Sep; 127(Pt A):169-77. PubMed ID: 25790721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery.
    Hocker JR; Lerner M; Lightfoot SA; Peyton MD; Thompson JL; Deb S; Reinersman M; Hanas RJ; Postier RG; Edil BH; Burkhart HM; Hanas JS
    PLoS One; 2020; 15(8):e0234539. PubMed ID: 32756554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.
    Liu Y; Liu JE; He H; Qin M; Lei H; Meng J; Liu C; Chen X; Luo W; Zhong S
    Cardiovasc Diabetol; 2024 Jan; 23(1):14. PubMed ID: 38184583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic impairments associated with type 2 diabetes mellitus and the potential effects of exercise therapy: An exploratory randomized trial based on untargeted metabolomics.
    Zhang F; Chen X; Yang M; Shen X; Wang Y; Zhong D; Zeng F; Jin R
    PLoS One; 2024; 19(3):e0300593. PubMed ID: 38517904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
    Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
    J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning reveals serum myristic acid, palmitic acid and heptanoylcarnitine as biomarkers of coronary artery disease risk in patients with type 2 diabetes mellitus.
    Hu T; Zhang W; Han F; Zhao R; Liu H; An Z
    Clin Chim Acta; 2024 Mar; 556():117852. PubMed ID: 38438006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Vitamin D Metabolites Levels Were Associated With Increased Coronary Artery Diseases in Type 2 Diabetes Patients in India.
    Adela R; Borkar RM; Bhandi MM; Vishwakarma G; Reddy PN; Srinivas R; Banerjee SK
    Sci Rep; 2016 Nov; 6():37593. PubMed ID: 27883024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS.
    Lu Y; Wang Y; Ong CN; Subramaniam T; Choi HW; Yuan JM; Koh WP; Pan A
    Diabetologia; 2016 Nov; 59(11):2349-2359. PubMed ID: 27514531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
    Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
    Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
    Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
    Tian C; Qiu M; Lv H; Yue F; Zhou F
    J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
    Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
    J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus.
    Gu X; Al Dubayee M; Alshahrani A; Masood A; Benabdelkamel H; Zahra M; Li L; Abdel Rahman AM; Aljada A
    Front Mol Biosci; 2020; 7():609806. PubMed ID: 33381523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum untargeted metabolomics analysis of the mechanisms of evodiamine on type 2 diabetes mellitus model rats.
    Yu Y; Lu Q; Chen F; Wang S; Niu C; Liao J; Wang H; Chen F
    Food Funct; 2022 Jun; 13(12):6623-6635. PubMed ID: 35635367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of sulfur-containing metabolites in discriminating fecal extracts between normal and type-2 diabetic mice.
    Walker A; Lucio M; Pfitzner B; Scheerer MF; Neschen S; de Angelis MH; Hartmann A; Schmitt-Kopplin P
    J Proteome Res; 2014 Oct; 13(10):4220-31. PubMed ID: 24991707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENPP1 121Q functional variant enhances susceptibility to coronary artery disease in South Indian patients with type 2 diabetes mellitus.
    Sumi S; Ramachandran S; RamanKutty V; Patel MM; Anand TN; Mullasari AS; Kartha CC
    Mol Cell Biochem; 2017 Nov; 435(1-2):67-72. PubMed ID: 28497367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.